Global Head of Research
Boehringer Ingelheim Animal Health

Jan H. Spaas was born in Bilzen (Belgium). His high school majors were Latin and Mathematics. During this period, he was a passionate horseback rider, which was translated in winning a 2-fold bronze medal at European Championships and 3-fold bronze medal at Belgian Championships for juniors and young riders (show jumping).

He graduated as a veterinarian in 2010 at the Faculty of Veterinary Medicine of Ghent University (Belgium) and obtained his PhD at the Dept. of Comparative Physiology and Biometrics of the Faculty of Veterinary Medicine, Ghent University. In 2012 he co-founded Global Stem cell Technology (acquired by Boehringer Ingelheim in 2020) to develop regenerative therapies for the treatment of musculoskeletal diseases in horses and dogs and was the General Manager for 10 years.
In 2020 he was appointed visiting professor at the Dept. of Morphology, Imaging, Orthopedics, Rehabilitation and Nutrition from the Faculty of Veterinary Medicine, Ghent.

Other speakers

Marcio Kanas Executive Director Nomura Bank
Emmanuel Hanon CEO Vicebio
Sven Arnouts Business Development Manager Ghent University - Provaxs
Lourdes Mottier Head of Business Development Strategy Elanco Animal Health
Hans Nauwynck - Panelist Professor University of Ghent
Michael Hemprich - Moderator Director Business Development & Strategy Ceva
Stefaan Wera Chief Operating Officer/Co-founder Virovet
Joris Vandeputte - Moderator President and Founder VacciM
Lauren Carde - Moderator V.P. Operations and Regulatory Affairs Paul Dick and Associates
Klaus Hellmann - Moderator Founder Argenta
Vladimir Pucovsky Scientific Administrator EMA Europa
Jose Carlos Mancera - panelist Senior Clinical Manager Zoetis
Liesbeth Ceelen - Moderator CEO BioLizard
Stein Aerts - panelist Scientific Director & Group Leader VIB
Daniel Jameson - panelist CEO Biorelate
Johannes Charlier Managing Director Kreavet
Jan Wauters Science & Technology Counselor Flanders Investment & Trade
Roxane Feller Secretary General Animal Health Europe
Hans Van Der Weken Postdoctoral Researcher Ghent University
Niels Vander Elst Postdoctoral Researcher Ghent University & KULeuven
Jeroen De Buck Professor Veterinary Microbiology University of Calgary
Kathleen Marchal Professor Bioinformatics University of Ghent
Paul Hodgson Director of Operations VIDO
Nathalie Vanderheijden Coordinator fot the EUP AH&W University of Ghent
Ann Martens Dean of the Faculty of Veterinary Medicine Ghent University
Lionel Malbec Product Manager Quantoom Biosciences
Lucas Decuypere CEO Allegro
Jelena Suran CEO Apiotix Technologies
Matthias Hofer Managing Partner SC Group (Stonehaven Cozmix Group AG)
Mathieu Peyrou Global Pharmaceuticals Development Director CEVA
Steve Nanchen Head external innovation Elanco

Interested? Register now!

Register here